838 Ribosomal protein S19
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Mixed metal/non-metal compounds | 2 | 0.2 | 11× | not tested | |
| Organic acids and derivatives | 4 | 1.4 | 2.91× | not tested | |
| Homogeneous metal compounds | 7 | 4.4 | 1.61× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00120 | PHE | Phenylalanine | 3 |
| DB00128 | ASP | Aspartic acid | 2 |
| DB00134 | MET | Methionine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 222 |
| OHX | osmium (III) hexammine | 80 |
| Kmetal | POTASSIUM ION | 2 |
| UNX | UNKNOWN ATOM OR ION | 2 |